Complement Inactivating Agents

All categories
DBCAT001769Therapeutic categoryL04AJ

Compounds that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host. A DrugBank category of 16 drugs. 14 of them are approved.

ATC classification
Also known as
Agents, Complement Inactivating · Agents, Complement Inhibiting · Complement Cytolysis Inhibiting Agents · Complement Inhibiting Agents · Complement Inhibitors
Drugs

What you can answer from here — as of August 24, 2016

16DrugsEach linked to its full drug card
Listed above
19Drug targetsEvery drug–target pair in the class, with bond type
Sign in
183Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
5Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Complement Inactivating Agents share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In